title: [Treatment optimization of subclinical atherosclerosis in patients with ulcerative colitis].
abstract: In this article we assessed the positive impact of statins and omega-3 polyunsaturated fatty acids on achieving target lipid levels, acute phase proteins in patients with ulcerative colitis and subclinical atherosclerosis.
authors: I V
authors: IV
authors: Chopeĭ
authors: T M
authors: TM
authors: Ternushchak
authors: K I
authors: KI
authors: Chubirko
authors: O M
authors: OM
authors: Ternushchak
authors: M M
authors: MM
authors: Ternushchak
authors: O R
authors: OR
authors: Kalymon
mesh_terms: D000209:Acute-Phase Proteins / Q000378:metabolism; D050197:Atherosclerosis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D003093:Colitis, Ulcerative / Q000150:complications*; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D050356:Lipid Metabolism / Q000187:drug effects
chemical_list: D000209:Acute-Phase Proteins; D015525:Fatty Acids, Omega-3; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors